F
Fulcrum Therapeutics D
D
FULC
7.82000
USD
-0.04
(-0.45%)
مغلق
حجم التداول
14,736
الربح لكل سهم
-1
العائد الربحي
-
P/E
-790
حجم السوق
422,118,173
الأخبار المقالات
العنوان: Fulcrum Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.